Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-17

Clinical Trial Update: The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Hyoscine-n-butylbromide for nausea and pain after laparoscopic cholecystectomy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyoscine-n-butylbromide (hyoscine butylbromide)

Snippet

Sponsor: Saglik Bilimleri Universitesi | Conditions: Cholecystitis, Pain | Phase 4 | Status: COMPLETED